PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 30, 2005Circulation387 citations

Restricting Excessive Cardiac Action Potential and QT Prolongation

View Full Paper
NJNorbert JostLVLászló VirágMBMiklós Bitay

Structured PICO

P
Population
Preparations (ventricular trabeculae, papillary muscles, and ventricular myocytes) obtained from undiseased human organ donors.
I
Intervention
Pharmacological block of IKs using chromanol 293B (10 micromol/L), L-735,821 (100 nmol/L), and HMR-1556 (100 nmol/L and 1 micromol/L), alone or in combination with dofetilide (50 nmol/L) and adrenaline (1 micromol/L).
C
Comparator
Baseline conditions without IKs block, or comparison with IKr blockers sotalol and E-4031.
O
Outcome
Action potential duration (APD) and membrane currents (IKs, IKr).surrogate

Pharmacological IKs block has little effect on normal human ventricular action potential duration, but plays an important role in limiting APD prolongation when repolarization reserve is attenuated.

Abstract

BACKGROUND: Although pharmacological block of the slow, delayed rectifier potassium current (IKs) by chromanol 293B, L-735,821, or HMR-1556 produces little effect on action potential duration (APD) in isolated rabbit and dog ventricular myocytes, the effect of IKs block on normal human ventricular muscle APD is not known. Therefore, studies were conducted to elucidate the role of IKs in normal human ventricular muscle and in preparations in which both repolarization reserve was attenuated and sympathetic activation was increased by exogenous dofetilide and adrenaline. METHODS AND RESULTS: Preparations were obtained from undiseased organ donors. Action potentials were measured in ventricular trabeculae and papillary muscles using conventional microelectrode techniques; membrane currents were measured in ventricular myocytes using voltage-clamp techniques. Chromanol 293B (10 micromol/L), L-735,821 (100 nmol/L), and HMR-1556 (100 nmol/L and 1 micromol/L) produced a <12-ms change in APD while pacing at cycle lengths ranging from 300 to 5000 ms, whereas the IKr blockers sotalol and E-4031 markedly lengthened APD. In voltage-clamp experiments, L-735,821 and chromanol 293B each blocked IKs in the presence of E-4031 to block IKr. The E-4031-sensitive current (IKr) at the end of a 150-ms-long test pulse to 30 mV was 32.9+/-6.7 pA (n=8); the L-735,821-sensitive current (IKs) magnitude was 17.8+/-2.94 pA (n=10). During a longer 500-ms test pulse, IKr was not substantially changed (33.6+/-6.1 pA; n=8), and IKs was significantly increased (49.6+/-7.24 pA; n=10). On application of an "action potential-like" test pulse, IKr increased as voltage became more negative, whereas IKs remained small throughout all phases of the action potential-like test pulse. In experiments in which APD was first lengthened by 50 nmol/L dofetilide and sympathetic activation was increased by 1 micromol/L adrenaline, 1 micromol/L HMR-1556 significantly increased APD by 14.7+/-3.2% (P<0.05; n=3). CONCLUSIONS: Pharmacological IKs block in the absence of sympathetic stimulation plays little role in increasing normal human ventricular muscle APD. However, when human ventricular muscle repolarization reserve is attenuated, IKs plays an increasingly important role in limiting action potential prolongation.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Jost et al. (2005) studied this question.

synapsesocial.com/papers/69f14b962811130d0cde2226https://doi.org/10.1161/circulationaha.105.550111
Ask AI
Helpful
Bookmark
Share
View Full Paper